Patent · US Active

Method for lateral flow immunoassay

US12031983B2 · kind B2 · utility

0Cited by
1References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 15, 2021
Grant dateJul 9, 2024
Priority date
Expiry dateAug 25, 2042

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/587
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present disclosure relates to a novel method for lateral flow immunoassay (LFIA) by utilizing plasmonic enhancement strategy. More specifically, the present disclosure provides a plasmonic enhanced lateral flow sensor (pLFS) concept by introducing a liposome-based amplification of the colorimetric signals on the lateral flow platform for ultrasensitive detection of pathogens.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.